The open day focused upon a number of projects overseen by CPI, including ReMedieES (RE-configuring MEDicines End-to-end Supply), which, alongside GlaxoSmithKline and AstraZeneca, saw CPI develop and scale up smart packaging concepts using printed electronics.
With smart packaging carrying great potential for many industries, thanks to its ability to provide real-time data on temperature, humidity, shock, tampering, and counterfeiting of goods - REMEDIES examined how it could re-shape the multi-billion pound global medicine manufacture and supply sector.
Delegates were told of CPI’s work on product trials within REMEDIES, notably how condition and quality data was transferred to GlaxoSmithKline via the Internet of Things, as well as its development of superior barrier material for blister packaging.
Additionally, the open event saw presentations from TNO/Holst about the opportunities presented by the InSCOPE project, which supplies a pilot line service to advance the accuracy and reliability of hybrid printable electronics.
InSCOPE supports large organizations, newcomers and SMEs in transforming flexible electronics technologies into novel products.